Nxera Pharma Co. Ltd. (JSS)
Market Closed
11 Aug, 20:00
€
4. 92
-0.06
-1.2048%
€
554.97M Market Cap
- P/E Ratio
- Div Yield
5 Volume
- Eps
€ 4.98
Previous Close Want to track JSS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nxera Pharma Co. Ltd. (JSS) Statistics
Valuation metrics
Market Cap 554.97M
Enterprise value 242.79M
Trailing P/E (ttm) 61.43
Forward P/E -
PEG ratio -0.72
Price/Sales (ttm) 0.02
Price/Book (mrq) 1.61
Enterprise Value/Revenue 1.31
Enterprise Value/EBITDA 32.93
Overview
Shares outstanding 91.73M
Float 68.93M
Shares short -
% Held by insiders 0.18%
% Held by institutions 0.37%
Average volume (10 days) 4
Average volume (90 days) 3
Price summary
52-Week low 4.04
52-Week high 6.55
Beta 0.17
50-Day moving average 5.23
200-Day moving average 4.99
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 4:1
Last split Date 27 Jun 2018
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.29%
Operating margin 0.29%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.15%
Income Statement
Revenue (ttm) 185.55M
Revenue per share (ttm) 378.51
Quarterly revenue growth (yoy) 0.69%
Gross profit (ttm) 143.8M
EBITDA 7.37M
Net income to common (ttm) -54.09M
Diluted EPS (ttm) -0.75
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 62.87M
Total cash per share (mrq) 128.15
Total debt (mrq) 302.67M
Total Debt/Equity (mrq) 87.66
Current ratio (mrq) 2.61%
Book value per share (mrq) 3.8
Cash Flow
Cash flow statement -26.75M
Levered free cash flow (LFCF) -74.94M
